Industry »Biotechnology« (7)

Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.

Results 7 matches

SYMBOL	INDUSTRY	MKT CAP	VRT	SIGNAL	SAFETY	RS	DIV. YIELD
REGN _NASDAQ Regeneron Pharmaceuticals	Biotechnology Ophthalmology, Immunology, Oncology, Cholesterol	81.3B	72	0.06	81	77	0.5%
UCB _BR UCB	Pharmaceuticals Neurology, Immunology, Epilepsy, Allergies	46.0B	46	-0.53	76	17	0.4%
RPRX _NASDAQ Royalty Pharma	Pharmaceuticals Biopharmaceutical Royalties, Rare Disease	33.8B	54	0.31	22	87	1.9%
BANB _SW Bachem Holding	Chemicals Peptide APIs, Oligonucleotides, NCEs, Generics	7.43B	51	0.49	84	82	0.6%
ALK-B _CO ALK-Abelló	Biotechnology Allergy Immunotherapy, Emergency Treatment	6.69B	53	-1.01	83	15	0.8%
BION _SW BB Biotech	Biotechnology Equity Fund, Biotechnology Investments	3.48B	41	-0.50	31	76	5.3%
BIOA-B _ST BioArctic (publ)	Biotechnology Alzheimer Treatment, Parkinson Research	2.87B	46	-0.85	56	40	0.6%

Technical

Rel Strength IBD > 80

Peers Outperformer

Tailwind

Signal > 0.5

Beta < 1.0

Structure

Near 52w High

Pullback Recovery

Not Overextended

Fundamental

RoIC > 15%

Debt / EBITDA < 3

Debt / Equity < 2

Stable EPS Growth

Stable Rev Growth

Dividend Yield & Growth

Notable Yield > 2%

High Yield > 5%

Very High Yield > 8%

Yield on Cost 5y > 10%

Dividend Growth > 0%

Dividend Growth > 5%

Dividend Consistency

Consistency > 85%

Consistency > 95%

Years > 5

Years > 10

Years > 25

Min 4 Payouts/Year

Min 10 Payouts/Year